Abstract
Thymosin beta-4 (Tβ4) is an actin-binding intracellular peptide that promotes wound healing, tissue remodeling, and angiogenesis. The mechanism of Tβ4 secretion to the extracellular environment is not understood. The macrophage is a rich source of Tβ4 which also participates in wound healing process. The objective of this study was to find how Tβ4 may be externalized. Using activation of macrophage through their toll-like receptors (TLR), the changes in cellular Tβ4 was studied. A naturally transformed chicken macrophage cell line HTC was treated with different TLR agonists and the cellular Tβ4 changes was determined at 6 and 24 h after stimulations using stable isotope labelling of amino acids in cell culture (SILAC) and mass spectrometry. Real time PCR was used to determine changes in gene expression. The results showed that TLR agonists such as peptidoglycan (PGN) or lipopolysacharide (LPS) caused depletions in cellular Tβ4 peptide along with its detection in the cell culture supernatant at 24 h. These TLR agonists also induced the expression of interleukins-1β, -6, and nitric oxide synthase genes at 6 h but failed to modulate Tβ4 gene at that time point indicating that the Tβ4 externalization was not associated with its production. To find whether Tβ4 externalization was associated with cell death, we measured the lactate dehydrogenase (LDH) activity of the conditioned media as an indicator of cell damage. The results showed that the TLR agonists which induced depletion of intracellular Tβ4 at 24 h also increased the LDH content of the conditioned media, suggesting that the Tβ4 in the extracellular media most likely originated from dying macrophages.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Thymosin beta-4 (Tβ4) is a highly conserved polypeptide originally identified as T cell maturation factor in the thymus gland that occurs ubiquitously in different cells and tissues of many organisms [1, 2]. Tβ4 binds to cytoplasmic G-actin preventing its polymerization to F-actin, thereby regulating cytoskeletal organization and cell motility [3, 4]. Extracellular Tβ4 promotes a variety of physiological functions such as wound healing, chemotaxis, angiogenesis, and down regulates inflammation [5–8]. Tβ4 apparently possesses antimicrobial activities, facilitates antigen presentation, and it is one of the major genes up-regulated following immune activation [9, 10]. Although Tβ4’s many diverse extracellular effects have been demonstrated, the regulation of its synthesis and secretion to the extracellular environment are not understood [7, 11].
In the course of screening for bioactive peptides in phagocytic cells, we identified Tβ4 as an abundant peptide present in chicken macrophages [12]. The macrophages constitute a major component of innate immunity and participate in many functions attributed to Tβ4 such as, wound healing, angiogenesis, and tissue remodeling [13–15]. The macrophages recognize various microbial pathogens and their products through a series of ‘pattern recognition receptors (PRRs)’ called toll-like receptors (TLRs) [16] which cause their activation leading to the synthesis and secretion of various cytokines, metabolites, and enzymes that in turn mediate their different biological effects [13, 17]. Therefore, the objective of this study was to find whether TLR activation can induce Tβ4 production by the macrophages which in turn may participate in post-inflammatory healing processes and other biological events attributed to this peptide.
Materials and methods
Reagents and chemicals
Dialyzed fetal bovine serum (FBS) and l-arginine and l-lysine deplete SILAC (stable isotope labelling of amino acids in cell culture) RPMI-1640 cell culture media were purchased from Pierce (Rockford, IL). 13C1 or ‘heavy isotope (H)’ labeled L-lysine, was obtained from Cambridge Isotope Laboratories (Andover, MA). Micro BCA protein assay kit (Pierce, Rockford, IL), RNAeasy mini and on-column DNA digestion kits (Qiagen Corp, Chatsworth, CA), Retroscript reverse transcriptase kit (Ambion, Austin, TX), SYBR green PCR master mix (Applied Biosystems, Austin, TX), and lactate dehydrogenase (LDH) cytotoxicity kit (Promega, Madison, WI) were purchased from the respective vendors. All other chemicals including l-lysine (L), l-arginine, non-enzymatic cell dissociation medium, and the antibiotic antimycotic solution, were obtained from Sigma–Aldrich (St. Louis, MO).
Toll-like receptor ligands
The peptidoglycan-polysaccharide polymers PG-PS 10S (PGN), 5 mg rhamnose equivalent/ml of 0.85% saline, a sonicated cell wall preparation of Streptococcus pyrogenes, was a gift from BD Bioscience (San Jose, CA). A synthetic lipoprotein Pam3CSK4 (palmitoyl- 3-cysteine-serine-lysine-4; PAM), Salmonella typhimurium flagellin (FGN) and, guanine analog loxoribine (LOX) were purchased from Invivogen (San Diego, CA). The CpG-oligodeoxynucleotide (CpG-ODN 2006), corresponding to the sequence TCGTCGTTTTGTCGTTTTGTCGTT [18], was synthesized by Invitrogen (Carlsbad, CA). Salmonella typhimurium lipopolysaccharide (LPS) and dsRNA analog poly I: C was purchased from Sigma–Aldrich (St. Louis, MO). All TLR ligands were prepared as stock solutions in sterile water.
SILAC media
l-lysine and l-arginine were dissolved in sterile PBS at a stock concentration of 10 and 50 g/l, respectively, and filtered through a 0.2 μm filter. A stock concentration of 13C1-lysine (10 g/l) was similarly prepared and filtered. The “Light (L)” SILAC medium for the control cells was prepared by adding 2 mL of stock solution of l-arginine and 4 ml of l-lysine to 500 ml of depleted RPMI 1640 medium. The “Heavy (H)” SILAC medium was similarly prepared by adding 2 ml of l-arginine and 4 ml of 13C1-lysine stock solutions to 500 ml of depleted RPMI 1640 medium. Both ‘L’ and ‘H’ SILAC media were filtered and supplemented with 10% dialyzed FBS, 20 mM glutamine, and 1× concentrations of antibiotic antimycotic solution.
Macrophage culture and activation by TLR agonists for SILAC studies
Transformed chicken HTC macrophage [19] cultured in RPMI-1640 media containing 10% FBS and 1× concentration of antibiotic antimycotic solution were initially grown in normal RPMI 1640 medium. At ~80% confluence, the media was aspirated and the cells were detached using a non-enzymatic dissociation medium for 5 min, and washed with PBS three times by successive centrifugation at 380×g for 8 min each [12]. One half of the detached cells were reconstituted in ‘L’ RPMI medium and the other half in the ‘H’ SILAC RPMI medium and grown in separate flasks. Metabolic labeling of cells were done according to Ong and Mann [20] with six successive passages of cells in their respective media that theoretically labels the entire proteome of the cells with 90–100% efficiency. Both L and H labeled HTC cells were then detached and plated in triplicates at a concentration of 1 × 106 cells/ml/well in 12 well culture plates in their respective media and grown overnight at 37°C under 5% CO2. The plates were then centrifuged at 100 g and replaced with fresh media for respective experiments. Two time point experiments were performed consisting of 6 and 24 h stimulation with TLR ligands. In both cases, the H labeled cultures, were stimulated with the following TLR cognate agonists: TLR2, gram-positive bacterial peptidoglycan (PGN); TLR3, poly inosinic, cytidylic (poly I: C); TLR4, gram-negative LPS; TLR5, flagellin (FGN); TLR2/1, PAM3CSK4; TLR7, loxoribine (LOX), and TLR9 or avian equivalent TLR 21, CpG-ODN [16, 21]. The final concentrations of the agonists, PAM (1 μg/ml), PGN (1 μg rhamnose equivalent/ml), FGN (100 μg/ml), poly I: C (1 μg/ml), LOX (100 μM), CpG-ODN (5 μM), and LPS (1 μg/ml), were based on the values recommended by the suppliers or earlier literature [22, 23]. Sets of H labeled and all L labeled cultures were used as respective controls without the addition of TLR agonists (Fig. 1).
Sample preparation for MALDI-MS
After 6 and 24 h of stimulation with TLR agonists, the supernatant from each well were removed and centrifuged at 250×g for 10 min and the cell free conditioned media were saved for further extraction. Respective pelleted cells were added to the cells in the wells and lysed in 200 μl of 0.1% n-octyl β-glucopyranoside (OβG) by repeated trituration, and centrifuged at 21,000×g for 10 min to obtain the clear cell lysate. Aliquots of the lysates were diluted for further experiments. The conditioned media were extracted by mixing with equal volumes of 100% methanol containing 2% acetic acid to denature and precipitate proteins over a 16 h period at 4°C, and centrifuged at 21,000×g for 10 min to obtain the supernatant for Tβ4 analysis. The cell lysate and conditioned media extract of untreated control (C) cultures consisted of L and H labeled extract (CL and CH) whereas the TLR agonist treated groups (T) consisted of only H labeled samples (TH), based on labeling with their respective light or heavy isotope containing lysine (Fig. 1). Protein concentrations of both conditioned media extract and cell lysates were determined using micro BCA protein assay and normalized to equal concentrations in case of variations between different samples. The triplicates of the H labeled control and treatment samples (CH and TH, cell lysate and conditioned media extract) were used individually but the L labeled control samples (cell lysate and conditioned media extract) were pooled and used for respective mixing experiments (Fig. 1).
Aliquots of each extract was mixed with an equal volume of one molar 2,5-dihydroxybenzoic acid (DHB) in 90% methanol containing 0.1% formic acid and 2 μl of each was spotted onto a Bruker MTP 384 stainless steel MALDI target for preliminary screening. MALDI-TOF spectra was acquired over the m/z range 1–10 kDa in the positive ion reflector mode using a Bruker Reflex III MALDI-TOF mass spectrometer (Bruker Daltonik GMBH, Bremen, Germany) [12, 24]. The data were processed using Bruker Flex Analysis 2.4/3.0 software. Initial screening of the cell lysate and conditioned media extract samples of CL, CH, and TH was done to detect the presence of Tβ4 (m/z 4963, protonated molecule in CL and m/z 4,972, protonated molecule in both CH and TH corresponding to 9 deuterium atoms present in 9 heavy labeled lysine residues. Following preliminary identification, pooled control CL and individual CH or TH were mixed 1:1 to determine the intensity ratios of L and H Tβ4 associated spectra in the cell lysate or their respective conditioned media extracts. The intensity ratios (CH/CL) for controls and (TH/CL) for all treatment groups were determined by triplicate spotting of each sample resulting in nine observations per treatment group. The change in the intracellular Tβ4 content was calculated by dividing the intensity ratio TH/CL over CH/CL. The mean and the standard error of the mean (SEM) was calculated for controls and each treatment group using measurements obtained from individual sets of experiments calculated in triplicate at both 6 and 24 h periods (Fig. 1). The results were evaluated using Students t test and a P value ≤ 0.05 was considered significant. The quantitative assays with conditioned media could not be performed, since most conditioned media extract did not show any detectable Tβ4 even after concentrating the respective samples. However, in groups which showed cellular depletion, the released Tβ4 peptides were detectable in the corresponding conditioned media and identified qualitatively.
Activation of macrophages by TLR agonists for gene expression studies
In separate set of experiments, the HTC cells were seeded in triplicates at 1 × 106 cells/ml/well in RPMI 1640 media containing regular L-lysine as above and treated with TLR agonists for 6 h to determine the macrophage activation-induced changes in the gene expression and 24 h to collect supernatant for nitrite and lactate dehydrogenase (LDH) determinations. Total RNA was extracted from control and TLR agonist treated macrophage cultures using RNAeasy mini kit. Any contaminating DNA was subjected to on column digestion with RNase-free DNase 1 according to the manufacturer’s instructions. The cDNA was synthesized from RNA using Retroscript reverse transciptase kit. The gene-specific primers for Tβ4, IL-6, IL-1β, iNOS, and the β-actin were designed with the Primer 3 software (http://frodo.wi.mit.edu/) (Table 1). The expression of genes for IL-6, IL-1β, and iNOS was used as positive indicators of macrophage activation, and β-actin as the reference. Quantitative polymerase chain reaction (qPCR) was done using two individual samples in each treatment group to determine the expression of target genes relative to β-actin. Real-time qPCR was performed following optimization of primer concentration and an ABI Prism 7700 Sequence Detector (Applied Biosystems, Austin, TX). Each mRNA sequence was amplified in duplicate in 25 μl reaction mixtures containing SYBR green PCR master mix (Applied Biosystems, Austin, TX); cDNA corresponding to 1 μg of reverse transcribed RNA, and 200 nM (optimized concentration) of forward and reverse primers. Both a no template and no reverse transcriptase control were included for each amplification reaction, and the homogeneity of the amplified products was confirmed routinely by melting curve analysis. The results were analyzed by the standard curve method and normalized to β-actin gene used as an endogenous control. The fold changes in the expression of target genes (Tβ4, IL-6, IL1β, and iNOS) in TLR agonist stimulated macrophages were determined relative to non stimulated control cultures.
Nitrite and LDH measurement
The nitrite content of aliquots of conditioned media from different treatment groups was measured using Griess reagent [19]. The percent changes in nitrite content were calculated relative to the untreated control. The LDH activity of the same conditioned media from both 6 and 24 h cultures were measured used to assess cell damage or death [25] using a LDH cytotoxicity assay kit according to the manufacturer’s protocol. The LDH activity was expressed as arbitrary fluorescence units (AU).
Statistics
All the quantitative results were evaluated using Students t test. A P value ≤ 0.05 was considered significant.
Results
TLR activation-induced Tβ4 release
MALDI-MS profiles of 1:1 mixtures of L and H cell extracts or similarly treated conditioned media extracts are shown in Figs. 2, 3, and 4. The figures represent the region of the spectra corresponding to the occurrence of Tβ4. Protonated ion m/z 4963 corresponds to Tβ4 peptide (12) while m/z 4972 corresponds to 9 residues of 13C1 labeled H lysine present in Tβ4. Signal intensities of L and H Tβ4 were monitored at 6 h and 24 h time points. Figure 2 (top panel) shows the MALDI-MS spectrum of a 1:1 mixture of L and H labeled control cell lysates whereas bottom panels represent spectra from 1:1 mixture of control (L) and respective TLR agonist stimulated H cell lysates at 6 h. The signal intensity of L and H labeled Tβ4 remained approximately the same in all groups in cell lysates at 6 h where as in the corresponding conditioned media extract it was below the detection limit (data not shown). At the 24 h time point, the cell-associated Tβ4 showed significant decreases in PGN, PAM, and LPS treated H cell lysates while CpG and FGN treatments showed moderate decreases with poly I: C and LOX showing no changes (Fig. 3). The significant decreases in the intensities of H Tβ4 detected in PGN, PAM, and LPS groups, was consistent with the detection of Tβ4 in their respective conditioned media both as intact peptides and their respective oxidized forms (Tβ4 sulfoxide L: m/z 4979, H: m/z 4988; Fig. 4). The oxidized form appeared to be dominant H labeled Tβ4 in the conditioned media (Fig. 4). The relative changes in cellular Tβ4 in macrophages treated with different TLR agonists at 6 and 24 h are shown in Fig. 5. While the cellular Tβ4 showed no change by any treatment at 6 h, at 24 h time point the PGN, PAM, and LPS caused significant decreases in cellular Tβ4 levels (P ≤ 0.001) with CpG and FGN showing a moderate albeit statistically significant decreases (P ≤ 0.05).
Gene expression
qPCR results of the expression of Tβ4, IL-1β, IL-6, and iNOS mRNA relative to β-actin is shown in Fig. 6. Tβ4 mRNA expression did not change significantly relative to untreated control group. In contrast, PAM, PGN, LPS, CpG, and FGN, all induced a significant up-regulation of IL-1β, IL-6, and iNOS. The FGN produced a lesser effect on comparison with other agonists whereas both poly I:C and LOX agonists showed minimal effects that were not significantly different from control (Fig. 6).
Functional activation of macrophages by TLR agonists
Cultures treated with TLR agonists, PGN, LPS, PAM, FGN, and CpG, showed changes in nitrite content of the conditioned media at both time points with much higher accumulation by 24 h relative to their controls. Except for poly I; C and LOX, rest other treatment groups showed a significant accumulation of nitrite at 24 h time points (Fig. 7).
LDH changes
There were no differences in LDH activities in the conditioned media between control and any TLR agonist treated cultures at 6 h time point but at 24 h, the LDH activity was significantly increased in all treatment groups except poly I: C and LOX. The conditioned media in all including that of control groups had higher LDH activities at 24 h compared with 6 h time point (Fig. 8).
Discussion
Thymosin β4 is a ubiquitously occurring peptide in eukaryotic cells which exerts a variety of extracellular effects including wound healing, angiogenesis, and tissue remodeling [6, 7, 26, 27]. Despite its diverse extracellular actions, the mechanism of its release into the extracellular fluid remains unclear. The Tβ4 also lacks a signal sequence which is essential for most secretory proteins and peptides [11]. However, the presence of Tβ4 in blister and wound fluids as well as in the conditioned media derived from bone marrow endothelial and myocardial cell cultures has suggested its secretion into the extracellular environment [28–30]. Our rationale to study the Tβ4 release was its abundance in macrophages [12, 31, 32] and these cells, when subjected to immunomodulation by TLR-agonists show increase in their secretory activities [33]. SILAC is a very sensitive and quantitative method to measure changes in protein and peptide expressions using the corresponding MALDI MS signal ratio of the light (L) and heavy (H) labeled peptide ions [34, 35]. Addition of 1 Da for each lysine residue due to 13C1 in H labeled peptide, compared to the natural abundance 12C labeled L, showed the expected overall 9 Da shift in mass consistent with the 9 lysine residues in mature chicken Tβ4. The ratios of the MALDI signals of these ions were measured to determine the expression differences. Our results showed no discernible changes in either cellular or conditioned-media associated Tβ4 at 6 h in any treatment group. In contrast, a significant decrease in cellular Tβ4 content was observed at 24 h in conditioned media of cultures treated with PGN, LPS, PAM, or CpG. Interestingly, not only L and H Tβ4 but their corresponding oxidized forms (Tβ4 sulfoxide) resulting from oxidation of single methionine residue showing a molecular mass increase of 16 Da were also detected in 24 h conditioned media [12, 36]. The H Tβ4 sulfoxide appeared to be the dominant species. The Tβ4 sulfoxide has been suggested as an anti-inflammatory mediator produced by the monocytes and macrophages by the action of glucocorticoids [36–38]. But, the mechanisms favoring the oxidation of Tβ4 to its sulfoxide form in conditioned media in the absence of glucocorticoids is not clear. It is likely that the phagocytic HTC cells which show respiratory burst when challenged with stimulants such as LPS [19] contribute to the formation of Tβ4 sulfoxide by extracellular oxidation of Tβ4.
The lack of any substantial effects of LOX, FGN, and poly I:C on HTC cells suggest that either these cells lack their cognate receptors or the concentrations were not sufficient enough to induce their activation. Our choice of TLR agonists and their effective concentrations were primarily based on literature reports. Based on the 24 h results, it is nonetheless, evident that at least, some TLR agonists are able to induce Tβ4 release into the culture media implying that similar mechanisms may be operative in vivo during inflammation and tissue remodeling events. Hence, we asked if Tβ4 was released by secretion induced by those agonists, then it should also be replenished in the cells and would be evident by the changes in its gene expression. The gene activation being an early event, we monitored its expressions along with the changes in the expressions of IL-1β, IL-6, and iNOS as positive indicators of macrophage activation, at 6 h. The changes in the nitrite levels in cell culture supernatants at both time points were also measured. The results showed that none of the TLR agonists modulated the expression of the Tβ4 gene implying that its expression may not be controlled by the factors that activate macrophages. The changes in the expression of IL-1β, IL-6, and iNOS genes and the release of nitrite into the conditioned media affected by PGN, LPS, PAM, and CpG, is consistent with HTC cell activation [19]. The mRNA expression is conventionally regarded to reflect the changes in their respective proteins or peptides. Therefore, the absence of any detectable change in Tβ4 gene expression coupled with the observed intracellular and extracellular changes in the levels of this peptide was intriguing. Alternatively, the possibility remained that the cell damage could cause the release of Tβ4 into the conditioned media. Lactate dehydrogenase (LDH) is a cytoplasmic enzyme, the leakage of which into the extracellular medium has been used as an indicator of cell damage and the loss of cell viability [25]. To assess whether some of the TLR agonists mediate the release of Tβ4 into the culture media by causing cell damage, we measured the LDH changes in cell culture supernatants. There were significant increases in LDH levels of the culture media treated with LPS, PGN, PAM, and CpG. These were the same treatment groups which showed the depletion of cellular Tβ4 at 24 h and its detection in the conditioned media extracts. Therefore, it appears that macrophage death induced by the action of these TLR agonists may be a possible explanation for the release of Tβ4 into the extracellular environment. This assumption is consistent with the fact that both gram-positive and gram-negative microbial products such as PGN and LPS do induce macrophage cell damage and death [39–41].
In conclusion, these results demonstrate that one of the mechanisms through which the immunomodulatory and inflammatory agents mediate the release of Tβ4 into extracellular environment is by inducing the damage and death of activated cells that subsequently helps repair processes. We believe these results provide a mechanism for Tβ4 release into wound environment and its role in post inflammatory healing.
Abbreviations
- AU:
-
Arbitrary units
- CpG-ODN:
-
CpG oligodeoxynucleotide
- DHB:
-
2,5-dihydroxybenzoic acid
- FGN:
-
Flagellin
- H:
-
Heavy isotope 13C-lysine label
- IL:
-
Interleukin
- iNOS:
-
Inducible nitric oxide synthase
- L:
-
Light lysine label
- LOX:
-
Loxoribine
- LPS:
-
Lipopolysaccharide
- MALDI-TOF:
-
Matrix-assisted laser desorption ionization-time of flight
- MS:
-
Mass spectrometry
- m/z:
-
Mass/charge
- PGN:
-
Peptidoglycan
- poly I:C:
-
Poly (inosinic:cytidilic acid)
- qPCR:
-
Quantitative polymerase chain reaction
- RT-PCR:
-
Reverse transcription-polymerase chain reaction
- SILAC:
-
Stable isotope labelling of amino acids in cell culture
- TLR:
-
Toll-like receptor
References
Goldstein AL (2007) History of the discovery of the thymosins. Ann N Y Acad Sci 1112:1–13
Huff T, Muller CS, Otto AM et al (2001) beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33:205–220
Safer D, Elzinga M, Nachmias VT (1991) Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 266:4029–4032
Sun HQ, Kwiatkowska K, Yin HL (1995) Actin monomer binding proteins. Curr Opin Cell Biol 7:102–110
Smart N, Rossdeutsch A, Riley PR (2007) Thymosin beta4 and angiogenesis: modes of action and therapeutic potential. Angiogenesis 10:229–241
Malinda KM, Sidhu GS, Mani H et al (1999) Thymosin beta4 accelerates wound healing. J Invest Dermatol 113:364–368
Goldstein AL, Hannappel E, Kleinman HK (2005) Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 11:421–429
Philp D, Goldstein AL, Kleinman HK (2004) Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev 125:113–115
Tang YQ, Yeaman MR, Selsted ME (2002) Antimicrobial peptides from human platelets. Infect Immun 70:6524–6533
Smith J, Speed D, Law AS et al (2004) In-silico identification of chicken immune-related genes. Immunogenetics 56:122–133
Mannherz HG, Hannappel E (2009) The beta-thymosins: Intracellular and extracellular activities of a versatile actin binding protein family. Cell Motil Cytoskeleton 66:839–851
Kannan L, Rath NC, Liyanage R et al (2007) Identification and characterization of thymosin beta-4 in chicken macrophages using whole cell MALDI-TOF. Ann N Y Acad Sci 1112:425–434
Ross JA, Auger M (2002) The biology of the macrophage. In: Burke B, Lewis CE (ed) The macrophage. Oxford University Press, Oxford, UK, pp 1–72
Rath NC, Kannan L, Liyanage R et al (2007) Thymosin beta in macrophage. J Endocrinol Reprod 11:55–61
Crowther M, Brown NJ, Bishop ET et al (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70:478–490
Kaisho T, Akira S (2006) Toll-like receptor function and signaling. J Allergy Clin Immunol 117:979–987
Hume DA (2006) The mononuclear phagocyte system. Curr Opin Immunol 18:49–53
Xie H, Raybourne RB, Babu US et al (2003) CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line. Dev Comp Immunol 27:823–834
Rath NC, Parcells MS, Xie H et al (2003) Characterization of a spontaneously transformed chicken mononuclear cell line. Vet Immunol Immunopathol 96:93–104
Ong S-E, Mann M (2007) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protocols 1:2650–2660
Brownlie R, Zhu J, Allan B et al (2009) Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol Immunol 46:3163–3170
Kannan L, Liyanage R, Lay JO Jr et al (2009) Evaluation of beta defensin 2 production by chicken heterophils using direct MALDI mass spectrometry. Mol Immunol 46:3151–3156
Kogut MH, Iqbal M, He H et al (2005) Expression and function of Toll-like receptors in chicken heterophils. Dev Comp Immunol 29:791–807
Kannan L, Rath NC, Liyanage R et al (2009) Direct screening identifies mature beta-defensin 2 in avian heterophils. Poult Sci 88:372–379
Vanderlinde RE (1985) Measurement of total lactate dehydrogenase activity. Ann Clin Lab Sci 15:13–31
Grant DS, Rose W, Yaen C et al (1999) Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3:125–135
Sosne G, Szliter EA, Barrett R et al (2002) Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 74:293–299
Frohm M, Gunne H, Bergman AC et al (1996) Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237:86–92
Huang WQ, Wang QR (2001) Bone marrow endothelial cells secrete thymosin beta4 and AcSDKP. Exp Hematol 29:12–18
Bock-Marquette I, Saxena A, White MD et al (2004) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432:466–472
Gondo H, Kudo J, White JW et al (1987) Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes. J Immunol 139:3840–3848
Hannappel E, Xu GJ, Morgan J et al (1982) Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues. Proc Natl Acad Sci USA 79:2172–2175
Serhan CN, Brain SD, Buckley CD et al (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325–332
Ong SE, Blagoev B, Kratchmarova I et al (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376–386
Ong SE, Mann M (2007) Stable isotope labeling by amino acids in cell culture for quantitative proteomics. Methods Mol Biol 359:37–52
Chettibi S, Lawrence AJ, Young JD et al (1994) Dispersive locomotion of human neutrophils in response to a steroid-induced factor from monocytes. J Cell Sci 107(Pt 11):3173–3181
Jain AK, Moore SM, Yamaguchi K et al (2004) Selective nonsteroidal anti-inflammatory drugs induce thymosin beta-4 and alter actin cytoskeletal organization in human colorectal cancer cells. J Pharmacol Exp Ther 311:885–891
Young JD, Lawrence AJ, MacLean AG et al (1999) Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 5:1424–1427
Soler C, Valdes R, Garcia-Manteiga J et al (2001) Lipopolysaccharide-induced apoptosis of macrophages determines the up-regulation of concentrative nucleoside transporters Cnt1 and Cnt2 through tumor necrosis factor-alpha-dependent and -independent mechanisms. J Biol Chem 276:30043–30049
Marriott HM, Ali F, Read RC et al (2004) Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. FASEB J 18:1126–1128
Xaus J, Comalada M, Valledor AF et al (2000) LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 95:3823–3831
Acknowledgments
Thanks are due to Sonia Tsai, Scott Zornes, Dana Bassi, and Wally McDonner for assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kannan, L., Rath, N.C., Liyanage, R. et al. Effect of toll-like receptor activation on thymosin beta-4 production by chicken macrophages. Mol Cell Biochem 344, 55–63 (2010). https://doi.org/10.1007/s11010-010-0528-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-010-0528-0